
The House of Commons Select Committee on Science and Technology 2000 state that currently less than zzso of adult patients with solid zzso are entered into clinical zzso They recommend that increasing the number of adult cancer patients entering clinical trials must become a high zzso zzso providers need to prepare themselves for this proposed increase in trial participants by assessing the current status of care and implementing changes within the current infrastructure to provide optimal holistic zzso Cancer can change a patient's life either for better or for zzso At one extreme, having cancer leads to enhanced appreciation of life and closer bonds with zzso However, at the other extreme, cancer combined with its treatment is viewed as an event that evokes distress and emotional anguish taxing the zzso ability to zzso In the last 25 years, zzso to the advent of clinical trials, progress has been made in cancer zzso Clinical trials may be hailed as the zzso to many therapeutic zzso zzso are now available which can offer patients hope of zzso Nevertheless, many participants may fear, for the purpose of research, that they may be assigned to less than optimal therapy or that their care will be carried out in a sterile scientific atmosphere devoid of humane and personal zzso These and other reasons may cause unacceptable personal distress that zzso the potential therapeutic zzso Cancer diagnosis coupled with the ramifications of clinical trial involvement can have significant psychological zzso They may trigger the onset of a mood disorder or exacerbate a present zzso This article will identify mood disorders in the cancer population, focus on the zzso needs in the clinical trial arena and investigate the influence trial participation has on psychological zzso 

